Antimicrobial resistance Call launched
IMI has launched its Call for proposals on antimicrobial resistance. The deadline for submitting Expressions of Interest is 9 July 2012.
ABOUT IMI
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
FUTURE CALLS -
STAY UP TO DATE!
Find out about IMI's forthcoming Calls for proposals -
- 7th Call for proposals: indicative outlines of vaccines and relative effectiveness topics published
- 8th & 9th Calls for proposals: indicative titles available
FIND PROJECT PARTNERS
Use IMI's Partner Search Tool to find potential partners for Expressions of Interest in response to the Call for proposals on combatting antimicrobial resistance - NewDrugs4BadBugs (ND4BB).
NEW PROJECT PAGES - 3RD CALL ADDED
IMI has given its project pages a make over and updated them to include the newly-launched 3rd Call projects as well as more information on project achievements.
IMI NEWSFLASH 
- 30/04/2013 : RT @ECspokesScience: MGQ: "Brain research could help alleviate the suffering of millions of patients and those that care for them." #brainm…
- 30/04/2013 : #brainmonth starts tomorrow! IMI projects on schizophrenia, depression, autism, chronic pain cited in EC press info http://t.co/uFhs06ZZWB
SIGN UP FOR THE IMI INFO SESSION IN CYPRUS
The Cyprus Ministry of Health and other organisations will hold an info session on IMI in Nicosia, Cyprus on 3 July 2012. The aim of the event is to promote IMI Calls in the region.
Innovative Medicines Initiative 2010